Invert to Convert: Rethinking Patient Recruitment and Enrollment Strategies
Mark Summers, WIRB Copernicus Group
Despite all the advances in science, medicine and technology, clinical trials are stuck in a rut: Most have trouble meeting enrollment targets. It’s an analog problem in a digital world.
You could find hundreds, maybe thousands, of reasons why a specific study is slow to enroll, but 90 to 95 percent of those reasons come down to one or both of two root causes.
Find out more by reading this informative white paper.